217978-01-3

Usage

InChI:InChI=1/C9H9FO3/c1-2-13-9(12)7-4-3-6(11)5-8(7)10/h3-5,11H,2H2,1H3

Upstream product

• 65145-13-3 2-fluoro-4-hydroxybenzoic acid 
• 64-17-5 ethanol 

Downstream Products

• 114045-96-4 4-Benzyloxy-2-fluoro-benzoic Acid 
• 121669-85-0 2-Fluoro-4-hydroxy-benzoic acid (S)-1-methyl-heptyl ester 
• 497838-55-8 (S)-(+)-1-methylheptyl 2-fluoro-4-(4-hydroxybenzoyloxy)benzoate 
• 345963-90-8 ethyl 2-fluoro-4-(trifluoromethylsulfonyloxy)benzoate 
• 1207481-17-1 ethyl 4-[5-(4,4,4,3,3,2,2-heptaflurobutoxy)pentyl-1-oxy]-2-fluorobenzoate 
• 1207481-14-8 ethyl 4-[6-(4,4,4,3,3,2,2-heptaflurobutoxy)hexyl-1-oxy]-2-fluorobenzoate 
• 1190044-53-1 ethyl 2-fluoro-4-(cyclopropylmethoxy)benzoate 
• 1206967-78-3 tert-butyl 4-[2-(4-ethoxycarbonyl-3-fluorophenoxymethyl)pyridin-5-yl]piperidine-1-carboxylate 
• 65145-13-3 2-fluoro-4-hydroxybenzoic acid 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND

The present invention provides to a compound having melanin-concentrating hormone receptor antagonistic action and low toxicity, and useful as a agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound re

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having Formula 1 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids.

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having Formula 2 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids.

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Novel compounds having the Formulas 1 through 8, wherein the symbols have the meaning defined in the specification, and certain previously known compounds have been discovered to act as inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. The compound can also be used in co-treatment with retinoids.

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having Formula 1 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids.